Breaking News
October 22, 2018 - Breast cancer survival could be extended with two new drug combinations
October 22, 2018 - Researchers discover how acne-causing bacteria resist treatment
October 22, 2018 - Cancer trial shows treating the prostate with radiotherapy improves survival
October 22, 2018 - New hope for a drug to treat lymphedema symptoms
October 22, 2018 - Immune-Based Treatment Helps Fight Aggressive Breast Cancer, Study Finds
October 22, 2018 - Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC
October 22, 2018 - Paternal exercise has significant impact on child’s lifelong metabolic health
October 22, 2018 - Targeting specific genomic mutation in breast cancer improves survival
October 22, 2018 - Loss of tumor protein p53 helps cancer cells grow in hostile environment
October 22, 2018 - IDT to demonstrate CRISPR expertise at European-focused events
October 22, 2018 - Breathing through the nose improves memory consolidation
October 22, 2018 - Recreational Marijuana Now Legal in Canada
October 22, 2018 - Scientists reveal drumming helps schoolchildren diagnosed with autism
October 22, 2018 - A stage IV cancer patient discusses what it means to live well with serious illness
October 22, 2018 - In Kids with Autism, Short Questionnaire May Detect GI Disorders
October 22, 2018 - Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas
October 22, 2018 - Aspirin may be effective in preventing blood clots after knee replacement
October 22, 2018 - Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting
October 22, 2018 - Study shows potential positive impact of group prenatal care on birth outcomes
October 22, 2018 - Immunotherapy with pembrolizumab extends survival in metastatic or recurrent head and neck cancer
October 22, 2018 - Health Tip: Keep Ticks Away
October 22, 2018 - Obsessive-compulsive disorder – Genetics Home Reference
October 22, 2018 - Researchers find disrupted functional connectivity in cerebellum of adults with HF-ASD
October 22, 2018 - Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors
October 22, 2018 - Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma
October 22, 2018 - Overcoming bottlenecks in early drug discovery with the power of sound
October 22, 2018 - Scientists discover genes that contribute to ADHD development
October 22, 2018 - Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma
October 22, 2018 - FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis
October 22, 2018 - At-home biofeedback therapy effective in relieving difficult-to-treat constipation
October 22, 2018 - Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer
October 22, 2018 - People with periodontal disease less likely to reach healthy blood pressure ranges
October 22, 2018 - Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer
October 22, 2018 - Primary care doctors ‘not doing enough’ to curb STDs
October 22, 2018 - Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer
October 22, 2018 - ImmunoGen announces study results of platinum-resistant ovarian cancer therapy at ESMO 2018 Congress
October 22, 2018 - Study findings could set new standard of care for advanced anal cancer
October 22, 2018 - Erlotinib improves progression-free survival in EGFR mutated NSCLC
October 22, 2018 - Pain, insomnia, and depression often drive osteoarthritis patients to seek medical care
October 22, 2018 - The International Society of Refractive Surgery honors Vivior Chairman with Casebeer Award
October 22, 2018 - Multi-strain probiotic helps reduce chemotherapy-induced diarrhea in cancer patients
October 22, 2018 - Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC
October 22, 2018 - Vertex gets European CHMP positive opinion for KALYDECO to treat patients with cystic fibrosis
October 22, 2018 - Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients
October 22, 2018 - Prostate radiotherapy improves survival in men with low burden of metastatic disease
October 22, 2018 - Duration of respiratory disturbances may better predict mortality risk from OSA
October 22, 2018 - Free phone app helps low-income obese patients to lose weight
October 22, 2018 - Immunotherapy with nivolumab and ipilimumab may improve survival in patients with MSI-high metastatic colorectal cancers
October 22, 2018 - FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma
October 22, 2018 - Compression Collar May Protect Brain of Female Soccer Players
October 22, 2018 - Technique visualizes neuron communication
October 22, 2018 - Advancement in medical imaging methods for health care
October 22, 2018 - Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis
October 22, 2018 - Immunotherapy increases survival in some patients with metastatic triple negative breast cancer
October 22, 2018 - Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma
October 22, 2018 - LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer
October 22, 2018 - Brainlab unveils ExacTrac Dynamic at ASTRO meeting in San Antonio, Texas
October 22, 2018 - Not exercising is worse than smoking, diabetes or heart disease finds study
October 22, 2018 - Shorter course of trastuzumab could be an option for women with HER2+ early breast cancer
October 22, 2018 - Map of Mouse Hippocampus Could Be Weapon Against Alzheimer’s
October 22, 2018 - Psychotropic polypharmacy is common in Alzheimer’s disease
October 22, 2018 - Texas A&M and UTA establish Texas Genomics Core Alliance
October 22, 2018 - Analyzing mouse’s potential as animal model of decision-making
October 22, 2018 - Radiotherapy can prolong survival in prostate cancer
October 22, 2018 - A genetic mutation involved in relapse
October 21, 2018 - Report reveals growing impact of cannabis on young people
October 21, 2018 - NSF awards $5 million grant to help scientists magnify societal impact of research
October 21, 2018 - Fertility Rates Down for Each Urbanization Level 2007 to 2017
October 21, 2018 - Genetically engineered 3-D human muscle transplant in a murine model
October 21, 2018 - Moms’ tight work schedules may affect their children’s sleep
October 21, 2018 - AHA: No Direct Link Between Preeclampsia and Cognitive Impairment, Study Finds
October 21, 2018 - Weight loss success linked with active self-control regions of the brain
October 21, 2018 - Scripps researchers successfully test potential new smoking-cessation treatment in rodents
October 21, 2018 - More accurate and less stressful way to measure a baby’s heartbeat
October 21, 2018 - Researchers show better cardiorespiratory fitness leads to longer life
October 21, 2018 - Healthy candies for diabetic patients
October 21, 2018 - Environment impact of microplastics remains unclear
October 21, 2018 - Antibiotics for appendicitis? Surgery often not needed
October 21, 2018 - AHA and AMA recognize more than 800 medical practices, health systems for blood pressure control
October 21, 2018 - Scientists obtain clearest ever image of Ebola virus protein
Non-invasive optical imaging detects early molecular signatures of disease

Non-invasive optical imaging detects early molecular signatures of disease

image_pdfDownload PDFimage_print

Chronic conditions including obesity, cardiovascular disease, and cancer often begin with early, subtle changes in cellular metabolism. Now researchers at Tufts University have developed a non-invasive optical imaging technique that detects these changes, providing an early window of opportunity for new research and potential therapeutic development.

“Before visible disease symptoms and damage occur, disease begins with changes in molecules involved in metabolism that hamper the ability of tissues and cells to function properly,” explained Behrouz Shabestari, Ph.D., director of the program in Optical Imaging at the National Institute of Biomedical Imaging and Bioengineering. “This work from Tufts is an innovative and highly significant approach for detecting early molecular signatures of disease.”

The laboratory of Irene Georgakoudi, Ph.D., professor of Biomedical Engineering at Tufts and lead researcher on the study, specializes in using light to interact with the key molecules that run cellular metabolism. Their methods allow imaging of changes in these key molecules over time without disturbing or damaging the cells.

The group used a technique called two-photon excited fluorescence (TPEF) microscopy to monitor the activity of two molecules involved in numerous metabolic functions in all cells: nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FAD). Both NADH and FAD are key components of the cell’s continuous chemical reactions that store energy and then release that energy when needed to keep the cell alive and functioning.

TPEF imaging excites these molecules with a near infrared laser beam. The resultant fluorescent signal provides an optical tool to monitor physiologic and biochemical events within the cells, which could indicate dysfunction and disease onset.

To test whether the imaging system could identify irregularities in cell metabolism, the researchers used TPEF to image cultured cells in which they altered major metabolic processes where NADH and FAD have critical roles. Live cells that were used included heart cells, epithelial cells, stem cells, and brown adipose (fat) cells. By changing metabolic function while imaging NADH and FAD, they determined whether changes in the specific fluorescent patterns of these two molecules were good indicators of the health or function of the cell.

Cells were imaged under varying experimental conditions that alter normal metabolic processes involved in producing energy. Examples of the conditions tested include starving cells of glucose, growing cells in low oxygen levels (so energy production is inefficient), and exposing cells to cold temperature (affecting energy storage).

Under each of the experimental conditions, TPEF imaging revealed unique patterns and intensity profiles of fluorescence that indicated that NADH and FAD were in certain chemical forms or locations that could serve as a map to understand why a cell is not functioning properly.

“These results demonstrate the utility of this non-invasive imaging technique for identifying unhealthy cells that could be early indications of disease development,” said Georgakoudi. “By simultaneously combining the imaging and analysis of cells under multiple conditions we were able to see the presence of metabolic changes as well as their chemical nature at the single-cell level.”

The metabolic changes created in the cells are similar to changes that occur in diseases such as cancer, cardiovascular disease, and obesity. “We believe the technique will ultimately become an important new platform used to understand and detect such diseases early in the process,” said Georgakoudi. “TPEF will also be an invaluable tool to monitor metabolic changes in response to new treatments designed to slow or stop disease before the onset of tissue degeneration or damage.”

Source:

https://www.nibib.nih.gov/news-events/newsroom/metabolic-imaging-targets-early-signs-disease-development

Tagged with:

About author

Related Articles